185 related articles for article (PubMed ID: 27986811)
1. EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer.
Li JJ; Sun ZJ; Yuan YM; Yin FF; Bian YG; Long LY; Zhang XL; Xie D
J Biol Chem; 2017 Jan; 292(3):1112-1121. PubMed ID: 27986811
[TBL] [Abstract][Full Text] [Related]
2. EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration.
Ji XD; Li G; Feng YX; Zhao JS; Li JJ; Sun ZJ; Shi S; Deng YZ; Xu JF; Zhu YQ; Koeffler HP; Tong XJ; Xie D
Cancer Res; 2011 Feb; 71(3):1156-66. PubMed ID: 21266352
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases.
Miao H; Strebhardt K; Pasquale EB; Shen TL; Guan JL; Wang B
J Biol Chem; 2005 Jan; 280(2):923-32. PubMed ID: 15536074
[TBL] [Abstract][Full Text] [Related]
4. Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.
He J; Jin Y; Zhou M; Li X; Chen W; Wang Y; Gu S; Cao Y; Chu C; Liu X; Zou Q
Cancer Sci; 2018 Mar; 109(3):642-655. PubMed ID: 29274137
[TBL] [Abstract][Full Text] [Related]
5. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity.
Havel LS; Kline ER; Salgueiro AM; Marcus AI
Oncogene; 2015 Apr; 34(15):1979-90. PubMed ID: 24858039
[TBL] [Abstract][Full Text] [Related]
6. EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells.
Xuqing W; Lei C; Zhengfa M; Shengchun D; Xin F; Jianguo Q; Jianxin Z
Tumour Biol; 2012 Oct; 33(5):1419-27. PubMed ID: 22528941
[TBL] [Abstract][Full Text] [Related]
7. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
[TBL] [Abstract][Full Text] [Related]
8. EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.
Li G; Ji XD; Gao H; Zhao JS; Xu JF; Sun ZJ; Deng YZ; Shi S; Feng YX; Zhu YQ; Wang T; Li JJ; Xie D
Nat Commun; 2012 Feb; 3():667. PubMed ID: 22314363
[TBL] [Abstract][Full Text] [Related]
9. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
10. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Zhang H; Teng X; Liu Z; Zhang L; Liu Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
[TBL] [Abstract][Full Text] [Related]
12. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
[TBL] [Abstract][Full Text] [Related]
13. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture.
Duan L; Chen G; Virmani S; Ying G; Raja SM; Chung BM; Rainey MA; Dimri M; Ortega-Cava CF; Zhao X; Clubb RJ; Tu C; Reddi AL; Naramura M; Band V; Band H
J Biol Chem; 2010 Jan; 285(2):1555-68. PubMed ID: 19826000
[TBL] [Abstract][Full Text] [Related]
15. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
16. Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Bhatia S; Griego A; Lennon S; Oweida A; Sharma J; Rohmer C; Uyanga N; Bukkapatnam S; Van Court B; Raben D; Young C; Heasley L; Karam SD
Mol Cancer Ther; 2018 Sep; 17(9):2049-2059. PubMed ID: 29970482
[TBL] [Abstract][Full Text] [Related]
17. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.
Lee J; Seol MY; Jeong S; Kwon HJ; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
J Mol Endocrinol; 2015 Apr; 54(2):115-24. PubMed ID: 25608512
[TBL] [Abstract][Full Text] [Related]
18. Paxillin kinase linker (PKL) regulates Vav2 signaling during cell spreading and migration.
Jones MC; Machida K; Mayer BJ; Turner CE
Mol Biol Cell; 2013 Jun; 24(12):1882-94. PubMed ID: 23615439
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
20. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
